Arbutus Biopharma Corp. (ABUS)
4.68
+0.23
(+5.17%)
USD |
NASDAQ |
Oct 05, 16:00
4.68
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price to Book Value : 3.575 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.399 |
| October 01, 2026 | 3.483 |
| September 30, 2026 | 3.651 |
| September 29, 2026 | 3.582 |
| September 28, 2026 | 3.712 |
| September 25, 2026 | 3.705 |
| September 24, 2026 | 3.728 |
| September 23, 2026 | 3.705 |
| September 22, 2026 | 3.827 |
| September 21, 2026 | 3.819 |
| September 18, 2026 | 3.827 |
| September 17, 2026 | 3.873 |
| September 16, 2026 | 3.858 |
| September 15, 2026 | 3.865 |
| September 14, 2026 | 3.919 |
| September 11, 2026 | 3.911 |
| September 10, 2026 | 3.911 |
| September 09, 2026 | 3.949 |
| September 08, 2026 | 3.957 |
| September 04, 2026 | 3.934 |
| September 03, 2026 | 3.911 |
| September 02, 2026 | 3.896 |
| September 01, 2026 | 3.888 |
| August 31, 2026 | 3.880 |
| August 28, 2026 | 3.873 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.949 |
| August 26, 2026 | 3.964 |
| August 25, 2026 | 3.972 |
| August 24, 2026 | 3.972 |
| August 21, 2026 | 3.980 |
| August 20, 2026 | 3.644 |
| August 19, 2026 | 3.804 |
| August 18, 2026 | 3.697 |
| August 17, 2026 | 3.598 |
| August 14, 2026 | 3.567 |
| August 13, 2026 | 3.498 |
| August 12, 2026 | 3.506 |
| August 11, 2026 | 3.567 |
| August 10, 2026 | 3.506 |
| August 07, 2026 | 3.537 |
| August 06, 2026 | 3.468 |
| August 05, 2026 | 3.529 |
| August 04, 2026 | 3.376 |
| August 03, 2026 | 3.330 |
| July 31, 2026 | 3.315 |
| July 30, 2026 | 3.369 |
| July 29, 2026 | 3.277 |
| July 28, 2026 | 3.369 |
| July 27, 2026 | 3.369 |
| July 24, 2026 | 3.346 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed, Inc. | 29.93 |
| Pfizer Inc. | 1.834 |
| Gossamer Bio, Inc. | -- |
| Legend Biotech Corp. | 2.960 |
| ACADIA Pharmaceuticals, Inc. | 2.648 |
Price to Book Value Related Metrics
| PE Ratio | 5.974 |
| PS Ratio | 5.003 |
| Price | 4.68 |
| Earnings Yield | 16.74% |
| Market Cap | 924.93M |
| Operating PE Ratio | 6.166 |
| Normalized PE Ratio | 6.018 |